PP
DVAX

Paloma Partners’s Dynavax Technologies DVAX Stock Holding History

Paloma Partners’s Portfolio DVAX Stock Details DVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-25,113
Closed -$280K – 507
2024
Q3 		$280K Buy
+25,113
New +$277K 0.01% 829
2020
Q4 		– Sell
-18,439
Closed -$80K – 1777
2020
Q3 		$80K Buy
+18,439
New +$132K ﹤0.01% 1933
2019
Q1 		– Sell
-18,600
Closed -$170K – 1738
2018
Q4 		$170K Sell
18,600
-7,746
-29% -$85.7K 0.01% 1079
2018
Q3 		$327K Buy
+26,346
New +$356K 0.01% 1195
2018
Q1 		– Sell
-17,729
Closed -$331K – 2021
2017
Q4 		$331K Buy
+17,729
New +$356K ﹤0.01% 1500
2017
Q1 		– Sell
-12,220
Closed -$48K – 2012
2016
Q4 		$48K Buy
+12,220
New +$89.5K ﹤0.01% 1929
2014
Q4 		– Sell
-1,500
Closed -$21K – 1194
2014
Q3 		$21K Sell
1,500
-1,327
-47% -$19.1K ﹤0.01% 972
2014
Q2 		$45K Buy
+2,827
New +$42.6K ﹤0.01% 1064
2013
Q4 		– Sell
-17,551
Closed -$211K – 1035
2013
Q3 		$211K Buy
+17,551
New +$221K 0.01% 739

Other funds holding DVAX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Paloma Partners's DVAX Position: Q4 2024 in Review

Paloma Partners sold out of Dynavax Technologies (DVAX) in Q4 2024, closing a stake of 25,113 shares — an estimated $280K sold.

Paloma Partners first reported a position in DVAX in Q3 2013 and held it in 9 quarters. The position peaked at $331K in Q4 2017. 256 funds tracked by Wall St. Rank hold DVAX as of Q4 2024.

  • Paloma Partners reported no remaining Dynavax Technologies position as of Q4 2024 after selling out during the quarter.
  • Paloma Partners sold 25,113 Dynavax Technologies shares in Q4 2024, an estimated $280K.
  • Paloma Partners first reported a position in Dynavax Technologies in Q3 2013 and held it in 9 quarters.
  • Paloma Partners's Dynavax Technologies position peaked at $331K in Q4 2017.
  • 256 funds tracked by Wall St. Rank held Dynavax Technologies as of Q4 2024.

Based on Paloma Partners's 13F filing for Q4 2024, filed 14 Feb 2025.